Opportunistic Play on C&O Pharmaceutical 28 Jan 11
Before I start, I will like to emphasis that this short write up is to highlight a possible opportunistic (technical) play on C&O Pharmaceutical (“C&O”) with a horizon of 1-2 weeks (max) and not an in depth analysis on its fundamentals. In addition, I reiterate that this write-up is a general one and does not take into account of the reader’s risk profile. It may or may not be suitable to you.
7.2% YTD drop, 2nd worst performer
Among the companies listed in Table 1 below, C&O is the 2nd worst performer, just below Si Huan Pharmaceutical. In addition, it has also underperformed the FTSE Strait Times China index year to date (“YTD”) by about 6%.
Table 1: C&O Pharmaceutical's statistics vis-à-vis its peers
Short Name | Cur | Last Price | Analyst Consensus Px | Adj Mkt Cap (S$m) | Cur FY ... |
